Atlas Trials

Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma

Clinical trial NCT01238159 · COMPLETED

Trial details

NCT number
NCT01238159
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Start date
2010-08-01
Primary completion
2014-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.